Arca
Skip to content
Tools
Tools

L-Varlock Cage/Trial Implant Holder

Recall Z-1461-2017, part of FDA recall event 76494. See Kiscomedica's company page.

Kiscomedica S.A. started this Class II device recall on Jan 11, 2017 (voluntary: firm initiated); FDA lists it as terminated.

  • Classification: Class II
  • Started: Jan 11, 2017
  • Status: Terminated

Why It Was Recalled

Class II

Firm received a complaint of the tip holder breaking during use.

Record

Product
L-Varlock Cage/Trial Implant Holder, Reference HD0060, Kisco International, France. Product Usage: The L-Varlock Lumbar Cage is indicated for intervertebral body fusion procedures in skeletally mature patients with degenerative disc disease (DDD) of the lumbar spine at one or two contiguous levels from L2-S1. DDD is defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies. These DDD patients may also have up to Grade I spondylolisthesis at the involved level(s). L-Varlock Lumbar implants are to be used with autogenous bone graft and implanted via an open posterior approach. L-Varlock Lumbar implant is to be used with supplemental fixation. Patients should have at least six (6) months of non-operative treatment prior to treatment with an intervertebral cage.
Quantity
13 units
Lots and codes
Batch number: 15486
Distribution
Worldwide Distribution - US Nationwide in the states of MO and country of Switzerland.
Recalling firm
Kiscomedica S.A., Saint Priest, N/A, France
How the firm notified
Letter
FDA classified
Mar 14, 2017

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.